PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 19 No. 1
Pages: 1  2  3  
Previous
 

The Hidden Suffering of the Psychopath

By Willem H.J. Martens, M.D., Ph.D. | December 31, 2001
Dr. Martens is director of the W. Kahn Institute of Theoretical Psychiatry and Neuroscience and advisor of the Forensic Psychiatry Hospital in Assen, The Netherlands.

"Norman" was raised by his aunt, as his parents were divorced and neither were capable of or interested in caring for him. As a child and adolescent, he had numerous encounters with law enforcement for joyriding, theft, burglary, fraud, assault and battery. He was sent to reform school twice. When he was 21 years old, he was convicted of armed robbery and served a year and a half in jail. His only close friend was another violent criminal; he had many short-term relationships with girlfriends. At 29, he killed two strangers in a bar who had insulted him and was sentenced to forensic psychiatric treatment. Norman was diagnosed as a psychopath, according to Hare's Psychopathy Checklist (Hare et al., 1990).

Norman showed little improvement over the course of seven years of behavioral psychotherapy and became less and less motivated. The staff of the forensic psychiatric hospital considered him untreatable and intended to stop all treatment attempts. Norman's lawyer arranged for an examination by a forensic neurologist, who subsequently found that Norman suffered from severe cortical underarousal, 5-HT and MAO abnormalities, and concentration problems.

Norman was started on d,l-fenfluramine (Pondimin), a serotonin-releasing drug. (Fenfluramine was voluntarily withdrawn from the U.S. market in 1997 -- Ed.) Acute challenge doses (0.2 mg/kg to 0.4 mg/kg) produced significant dose-dependent decreases in impulsive and aggressive responses. After one month, an MAOI (pargyline [Eutonyl], 10 mg/kg) and psychodynamic psychotherapy were added. Pargyline produced some normalization of his electroencephalogram (EEG) pattern and was titrated up to 20 mg/kg over five months. Neurofeedback was started after two months and continued for 15 months. His EEG pattern gradually normalized, and his capacities for concentration and attention increased.

Norman continued to receive d,l-fenfluramine and psychotherapy for two years, at which point he was discharged from forensic treatment. He voluntarily continued psychotherapy for an additional three years and, in the four years since his release, has not reoffended.

Conclusions
 

 

It is extremely important to recognize hidden suffering, loneliness and lack of self-esteem as risk factors for violent, criminal behavior in psychopaths. Studying the statements of violent criminal psychopaths sheds light on their striking and specific vulnerability and emotional pain. More experimental psychopharmacological, neurofeedback and combined psychotherapeutic research is needed to prevent and treat psychopathic behavior.

The current picture of the psychopath, which is reflected in the leading diagnostic criteria of psychopathy offered by Cleckley (1982) and Hare et al. (1990), is incomplete because emotional suffering and loneliness are ignored. When these aspects are considered, our conception of the psychopath goes beyond the heartless and becomes more human.

 

 

Pages: 1  2  3  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by jason unsworth | January 04, 2011 3:28 AM EST

the emphasis has been on the psychopath who runs foul of the law (i.e., the serial killer in the provided examples) but we should not forget the middle class & corporate, high functioning psychopaths--those who are in medical practice, work in the stock exchange, police force etc. Such high functioners often go unrecognized until they present for treatment for mood disorders and the like. I have met such callous individuals who meet criteria for psychopathy but never run foul of the law.

by Chevies Newman | December 26, 2010 10:06 AM EST

Great Article. It is likely that much of the issue begins between birth and 2 y.o. This time frame sees the brain grow from roughly 400 gums to 1000 grams. The maternal "looping" phenomenon in which mothers are able to do the ga ga teaches social timing. If mom stressed and cannot even fake it, then this critical period of development, depending on genotype, creates high anxiety levels. Some children overcome and adapt but some find themselves on the outside looking in. This is lonely. The early antisocial behavior is likely stress relief. The thinking that evolves around a life of exclusion can truly be horrifying. Support for at risk mothers and early education in a warm environment, early mental health therapy to enhance and develop empathy by brain development would improve the lives of everyone, even those who eventually end up with the horrifying external expression of the internal state seen before all. We are all taken back. But it is the brain, deprived, hungry and desperate. As the adult with this problem, where is the starting point of reconstruction? Get on medicine, (something will help), because the obsession will increase with stress. Ensure your regimen helps with anxiety, make sure you are Asllep when supposed to be and awake when supposed to be. If not, you are not adequatley treated. Step 2 would be to refrain from harming others. Find other outlets if possible but treat the obsessions like obsessive compulsive disorder. Find the mythology, or change the one you have, to begin a new reconstruction. At least do step 1, this wll help to at least feel better and reduce obsession, if so the compulsion will get better and new learning occur. Good luck, if this is your issue, you are reading about it and thus must have a spark of hope.

by what unlisted | December 23, 2010 3:55 PM EST

The rest of these crying out comments, get help. 

by what unlisted | December 23, 2010 3:51 PM EST

edit*

prejudice is ridiculous. psychopathy and sociopathy are not currently mood disorders, but could be considered one, one day due to the total lack of mood all the time  and emotionless time periods in the psychopath  and the emotionless and moodless time periods in the sociopath. 

by what unlisted | December 23, 2010 3:50 PM EST

prejudice is ridiculous. psychopathy and sociopathy are not currently mood disorders, but could be considered one, one day due to the total lack of mood all the time  and emotionless time periods and the emotionless and moodless time periods in the sociopath. 

Article Comment Pages: 1 2 3 Next






COMMON MEDICATIONS
Lithium

References

Black DW, Baumgard CH, Bell SE, Kao C (1996), Death rates in 71 men with antisocial personality disorder. A comparison with general population mortality. Psychosomatics 37(2):131-136.

Bloom FE, Kupfer DJ, eds. (1994), Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press.

Cleckley HM (1982), Mask of Sanity. St. Louis: Mosby.

Dolan B (1998), Therapeutic community treatment for severe personality disorders. In: Psychopathy: Antisocial, Criminal and Violent Behavior, Millon T, Simonsen E, Birket-Smith M, Davis RD, eds. New York: Guilford Press, pp407-438.

Dolan B, Coid J (1993), Psychopathic and Antisocial Personality Disorders: Treatment and Research Issues. London: Gaskell.

Hare RD, Harpur TJ, Hakstian AR et al. (1990), The Revised Psychopathy Checklist: descriptive statistics, reliability, and factor structure. Psychological Assessment 2:338-341.

Hollander E (1999), Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. J Clin Psychiatry 60(suppl 15):38-44.

Lykken DT (1995), The Antisocial Personalities. Hillsdale, N.J.: Lawrence Erlbaum Assoc.

Martens WHJ (1997), Psychopathy and maturation. MD-dissertation, Tilburg University, The Netherlands. Maastricht: Shaker Publishing.

Martens WHJ (1999), Marcel -- A case report of a violent sexual psychopath in remission. International Journal of Offender Therapy and Comparative Criminology 43:391-399.

Martens WHJ (2000), Antisocial and psychopathic personality disorders: causes, course and remission -- a review article. International Journal of Offender Therapy and Comparative Criminology 44:406-430.

Martens WHJ (2001), Effects of antisocial or social attitudes on neurobiological functions. Medical Hypotheses 56(6):664-671.

Martens WHJ (in press), Neurobiologic and genetic aspects of psychopathic immorality. International Journal of Offender Therapy and Comparative Criminology.

Palermo GB, Martens WHJ (in press), Jeffrey Dahmer and Dennis Nilsen: A Double Portrait of Two Sadistic Serial Killers. Thousand Oaks, Calif.: Sage Publications.

Raine A (1996), Autonomic nervous system factors underlying disinhibited, antisocial, and violent behavior. Biosocial perspectives and treatment implications. Ann N Y Acad Sci 794:46-59.

Raine A, Lencz T, Bihrle S et al. (2000), Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 57(2):119-127, discussion 128-129 [see comments].

Sanislow CA, McGlashan TH (1998), Treatment outcome of personality disorders. Can J Psychiatry 43(3):237-250 [see comment p235].

Sheard MH, Marini JL, Bridges CI, Wagner E (1976), The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 133(12):1409-1413.

Tupin JP, Smith DB, Clanon TL et al. (1973), The long-term use of lithium in aggressive prisoners. Compr Psychiatry 14(4):311-317.

Zuckerman M (1994), Behavioral Expressions and Biosocial Bases of Sensation Seeking. New York: Cambridge University Press.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • The Moral Struggles of Practicing Psychiatrists
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Experts Discuss Changes, Updates in DSM-5
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • You Are—And Your Mood Is—What You Eat
  • Grief and Depression: The Sages Knew the Difference
  • Experts Discuss Changes, Updates in DSM-5
  • Developmental Psychopathology Comes of Age
  • The Psychiatrist and the Slot Machine
  • The Role of Biological Tests in Psychiatric Diagnosis
  • You Are—And Your Mood Is—What You Eat
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • Experts Discuss Changes, Updates in DSM-5
  • The Role of Biological Tests in Psychiatric Diagnosis
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Refinements in ECT Techniques
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy